Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial

BACKGROUND: In clinical practice, some cases indicated that the loading dose of bivalirudin increased the bleeding risk, particularly in patients with renal insufficiency. Therefore, this study aimed to assess the efficacy and safety of the low-dose (80%) bolus injection of bivalirudin in patients u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiang, Han, Ya-Ling, Zhou, Tie-Nan, Wang, Xiao-Zeng, Zhang, Quan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081606/
https://www.ncbi.nlm.nih.gov/pubmed/35548446
http://dx.doi.org/10.3389/fcvm.2022.864048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081606/
https://www.ncbi.nlm.nih.gov/pubmed/35548446
http://dx.doi.org/10.3389/fcvm.2022.864048

Ejemplares similares